Magnesium Chloride Versus Placebo in Patients Who Have Had a Stroke

Completed

Phase 2/3 Results N/A

Summary of Purpose

The purpose of this study is to evaluate the effect of six intravenous (IV) infusions of magnesium chloride versus placebo in patients who have residual muscle weakness from a stroke that occurred three months to four years ago.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 23 May 2012.

1 Apr 2009 30 Jun 2009 1 May 2010 1 Jul 2010 1 Sep 2010 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available